Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection
Clinical trial NCT02073656 · COMPLETED
Trial details
- NCT number
- NCT02073656
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-11-01
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.